Preferences of caregivers and patients regarding opioid analgesic use in terminal care.

CONTEXT Patients and caregivers participate in decision-taking, and their views should be considered in the preparation of Clinical Practice Guidelines (CPGs). We involved them in the development of a CPG on the safe use of major opioids. OBJECTIVE To identify the values and preferences of patients and caregivers on the use of opioids and the desired outcomes, to investigate motives for the acceptance/rejection of opioid therapy, and to evaluate their beliefs and information about these drugs. METHODS A qualitative study was conducted using semi-structured interviews in an Andalusian population of terminal patients and caregivers (N = 42). Study variables included the role, diagnosis, and adherence to treatment. Content and validity analyses were performed. RESULTS Less than one-third of participants recognized the term opioid. Among these, false beliefs were held related to the addictive nature of these drugs, their exclusive use in terminal cases and at the end of life, and their association with premature death. The information received was very general: it was known that they are "useful for pain," and some were informed about the administration route, composition, and habituation. Participation in decision making was usually limited to reporting symptoms to the physician. CONCLUSION These patients and caregivers demonstrated a preference for pain alleviation by opioid treatment and gave negative assessments on adverse digestive effects that can cause this treatment to be abandoned. They expressed interest in receiving more information and in participating in therapeutic decision making, and they reported erroneous beliefs and a lack of information about the effects of these drugs.

[1]  H. Kessel,et al.  Sedación terminal: el último recurso ante una «mala muerte» , 2003 .

[2]  Mellar P. Davis,et al.  Errors in opioid prescribing: a prospective survey in cancer pain. , 2010, Journal of pain and symptom management.

[3]  E. Guadagnoli,et al.  Patient participation in decision-making. , 1998, Social science & medicine.

[4]  A. Mencías,et al.  Consideraciones sobre el empleo de opioides en el dolor crónico del paciente geriátrico , 2008 .

[5]  A. Coulter After Bristol: putting patients at the centre. , 2002, BMJ : British Medical Journal.

[6]  C. Centeno,et al.  Uso apropiado de opioides y neurotoxicidad , 1999 .

[7]  V. Kouloulias,et al.  Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers. , 2004, The journal of pain : official journal of the American Pain Society.

[8]  L. Malysh,et al.  Intrathecal infusions for intractable cancer pain: a qualitative study of the impact on a case series of patients and caregivers. , 2009, Pain research & management.

[9]  Nathan I. Cherny,et al.  Morfina y opiáceos alternativos para el tratamiento del dolor oncológico: recomendaciones de la EAPC , 2002 .

[10]  F. Porreca,et al.  Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. , 2009, Pain medicine.

[11]  K. Flemming The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. , 2010, Journal of pain and symptom management.

[12]  A. Cámara,et al.  Herramientas para la práctica de la medicina basada en la evidencia (y II). Desarrollo de guías de práctica clínica basadas en la evidencia: de abajo-arriba , 2001 .

[13]  C. McPherson,et al.  After-death interviews with surrogates/bereaved family members: some issues of validity. , 2001, Journal of pain and symptom management.

[14]  Gill Hubbard,et al.  Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. , 2008, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[15]  C P Bradley,et al.  Misunderstandings in prescribing decisions in general practice: qualitative study , 2000, BMJ : British Medical Journal.

[16]  S. Barclay,et al.  What are patients' priorities for palliative care research? Focus group study , 2007, Palliative medicine.

[17]  E. Briones,et al.  Los pacientes en las guías de práctica clínica , 2008 .

[18]  E. Kalso,et al.  Morphine and alternative opioids in cancer pain: the EAPC recommendations , 2001, British Journal of Cancer.

[19]  A. Stiggelbout,et al.  Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration , 2008, British Journal of Cancer.

[20]  M. Lugo,et al.  El pacto de silencio en los familiares de los pacientes oncológicos terminales , 2008 .

[21]  Qualitative methods in end-of-life research: recommendations to enhance the protection of human subjects. , 2003, Journal of pain and symptom management.

[22]  A. A. Babarro Atención a la familia , 2006 .

[23]  B. Murnion,et al.  Prescription and administration of opioids to hospital in-patients, and barriers to effective use. , 2010, Pain medicine.

[24]  E. García,et al.  Plan Andaluz de Atención a las personas con dolor : 2010 - 2013 , 2010 .

[25]  A. Gracia,et al.  Citrato de fentanilo oral transmucosa en el tratamiento del dolor irruptivo en pacientes con cáncer en España: resultados del estudio EDIPAD , 2004 .

[26]  Yvonne H Carter,et al.  Knowledge and information needs of informal caregivers in palliative care: a qualitative systematic review , 2008, Palliative medicine.

[27]  La atención médica a la enfermedad crónica: reflexiones sobre los procedimientos metodológicos de un estudio cualitativo , 2002 .

[28]  Andrew D Oxman,et al.  Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[29]  C. Centeno,et al.  Metadona en el tratamiento del dolor por cáncer: experiencia del Hospital Los Montalvos, Salamanca , 2004 .

[30]  C. Centeno,et al.  Tratamiento y prevención del síndrome de neurotoxicidad inducido por opioides , 1999 .

[31]  D. Rothenbacher,et al.  Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about it. , 1997, European journal of cancer.

[32]  M. T. Anguera EVALUACIÓN DE PROGRAMAS DESDE LA METODOLOGÍA CUALITATIVA , 2008 .

[33]  R. Portenoy,et al.  Establishing "best practices" for opioid rotation: conclusions of an expert panel. , 2009, Journal of pain and symptom management.

[34]  S. Tregear,et al.  Long-term opioid management for chronic noncancer pain. , 2010, The Cochrane database of systematic reviews.

[35]  F. Percival,et al.  How much does it cost a specialist palliative care unit to manage constipation in patients receiving opioid therapy? , 2010, Journal of pain and symptom management.

[36]  N. Aziz,et al.  Palliative care research: issues and opportunities. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  M. Dunckley,et al.  What is important to measure in the last months and weeks of life?: A modified nominal group study. , 2006, International journal of nursing studies.

[38]  S. Tello,et al.  Uso de los opioides en pacientes con dolor oncológico , 2007 .

[39]  L. Jones,et al.  Acceptability of an advance care planning interview schedule: a focus group study , 2007, Palliative medicine.

[40]  S. Mercadante,et al.  When the Progression of Disease Lowers Opioid Requirement in Cancer Patients , 2010, The Clinical journal of pain.

[41]  J. Goepp,et al.  Provider Insights About Palliative Care Barriers and Facilitators: Results of a Rapid Ethnographic Assessment , 2008, The American journal of hospice & palliative care.